36148 Federal Register / Vol. 65, No. 110 / Wednesday, June 7, 2000 / Notices

fellowship program in infectious

diseases.

b. Staff and administrative (25 points):

The extent to which applicant describes

adequate resources and facilities

(clinical, academic, and administrative)

for conducting the PFTP. The extent to

which applicant documents that their

professional personnel involved in the

PFTP are qualified and have past

experience and achievements related to

that proposed as evidenced by

curriculum vitae, publications, etc. If

proposing that fellow’s research be

conducted at CDC facilities, the extent

to which applicant includes a Letter of

Support as described in Application

Content section 3.b., above (i.e., that is

signed by the appropriate CDC officials

and that clearly indicates their

commitment to participate as proposed

in the application).

3. Operational Plan (30 Points)

The extent to which the proposed

operational plan is clear, detailed, timephased, and meets the purpose and

goals of this cooperative agreement

program. The extent to which the

proposed operational plan addresses all

required Recipient Activities. If specific

fellow(s) research projects are proposed

that involve the use of human subjects,

the degree to which the applicant has

met the CDC Policy requirements

regarding the inclusion of women,

ethnic, and racial groups in the

proposed research. This includes:

a. The proposed plan for the inclusion

of both sexes and racial and ethnic

minority populations for appropriate

representation.

b. The proposed justification when

representation is limited or absent.

c. A statement as to whether the

design of the study is adequate to

measure differences when warranted.

d. A statement as to whether the plans

for recruitment and outreach for study

participants include the process of

establishing partnerships with

community(ies) and recognition of

mutual benefits.

4. Evaluation Plan (5 Points)

The quality of the proposed plan to

monitor, evaluate and track individual

fellows; and overall plan to evaluate

activities and objectives.

5. Budget (Not Scored)

The extent to which the proposed

budget is reasonable, clearly justified,

and consistent with the intended use of

cooperative agreement funds.

6. If research involving the use of

human subjects is proposed, does the

application adequately address the

requirements of Title 45 CFR Part 46 for

the protection of human subjects?

Yesll Noll

H. Other Requirements

Technical Reporting Requirements

Provide CDC with original plus two

copies of—

1. Annual progress reports (included

with each noncompeting continuation

application);

2. Financial status report, no more

than 90 days after the end of the budget

period; and

3. Final financial and performance

reports, no more than 90 days after the

end of the project period.

Send all reports to the Grants

Management Specialist identified in the

‘‘Where to Obtain Additional

Information’’ section of this

announcement.

The following additional

requirements are applicable to this

program. For a complete description of

each, see Attachment I in the

application kit.

AR–1 Human Subjects Requirements

AR–2 Requirements for Inclusion of

Women and Racial and Ethnic

Minorities in Research

AR–3 Animal Subjects Requirements

AR–7 Executive Order 12372 Review

AR–9 Paperwork Reduction Act

Requirements

AR–10 Smoke-Free Workplace

Requirements

AR–11 Healthy People 2010

AR–12 Lobbying Restrictions

I. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under

Sections 301 [42 U.S.C. 241] and

317(k)(2) [42 U.S.C. 247b(k)(2)] of the

Public Health Service Act, as amended.

The Catalog of Federal Domestic

Assistance Number is 93.283.

J. Where To Obtain Additional

Information

This and other CDC announcements

can be found on the CDC home page

Internet address—http://www.cdc.gov.

Click on ‘‘Funding’’ then ‘‘Grants and

Cooperative Agreements.’’

To receive additional written

information and to request an

application kit, call 1–888–GRANTS4

(1–888–472–6874). You will be asked to

leave you name and address and will be

instructed to identify the

Announcement number of interest.

If you have questions after reviewing

the contents of all the documents,

business management technical

assistance may be obtained from:

Andrea Wooddall, Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention,

Room 3000, 2920 Brandywine Road,

Atlanta, GA 30341–4146, Telephone

number: (770) 488–2749, Email address:

ayw3@cdc.gov.

For program technical assistance,

contact: Greg J. Jones, M.P.A., Office of

the Director, National Center for

Infectious Diseases, Centers for Disease

Control and Prevention (CDC), Mailstop

C–12, 1600 Clifton Road, N.E., Atlanta,

GA 30333, Phone: (404) 639–4180,

Facsimile: (404) 639–3106, Email:

GJJones@cdc.gov.

Dated: June 1, 2000.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 00–14267 Filed 6–6–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 00C–1321]

Wesley Jessen Corp.; Filing of Color

Additive Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Wesley Jessen Corp. has filed a

petition proposing that the color

additive regulations be amended to

provide for the safe use of mica in

contact lenses.

FOR FURTHER INFORMATION CONTACT:

Ellen M. Waldron, Center for Food

Safety and Applied Nutrition (HFS–

215), Food and Drug Administration,

200 C St. SW., Washington, DC 20204,

202–418–3089.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 721(d)(1) (21 U.S.C. 379e(d)(1))),

notice is given that a color additive

petition (CAP 0C0271) has been filed by

Wesley Jessen Corp., 333 East Howard

Ave., Des Plaines, IL 60018. The

petition proposes to amend the color

additive regulations in 21 CFR part 73

subpart D—Medical Devices to provide

for the safe use of mica in contact

lenses.

The agency has determined under 21

CFR 25.32(l) that this action is of a type

that does not individually or

cumulatively have a significant effect on

the human environment. Therefore,

neither an environmental assessment

Federal Register / Vol. 65, No. 110 / Wednesday, June 7, 2000 / Notices 36149

nor an environmental impact statement

is required.

Dated: May 15, 2000.

Laura M. Tarantino,

Acting Director, Office of Premarket

Approval, Center for Food Safety and Applied

Nutrition.

[FR Doc. 00–14272 Filed 6–6–00; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

Periodically, the Health Resources

and Services Administration (HRSA)

publishes abstracts of information

collection requests under review by the

Office of Management and Budget, in

compliance with the Paperwork

Reduction Act of 1995 (44 U.S.C.

Chapter 35). To request a copy of the

clearance requests submitted to OMB for

review, call the HRSA Reports

Clearance Office on (301)–443–1129.

The following request has been

submitted to the Office of Management

and Budget for review under the

Paperwork Reduction Act of 1995:

Proposed Project: The Health Education

Assistance Loan (HEAL) Program:

Forms (OMB No. 0915–0034) Extension

This clearance request is for extension

of approval for four HEAL forms: the

Lenders Application for Contract of

Federal Loan Insurance (used by lenders

to make application to the HEAL

insurance program); the Lender’s

Manifest (used by the lender to report

recent HEAL loan activity); the Loan

Transfer Statement (used by the lender

to report the transfer of a HEAL loan);

and the Borrower Status Request

(completed by the borrower and the

borrower’s employer and used by the

lender to determine eligibility for

deferment). The reports assist the

Department in protecting its investment

in this loan insurance program.

The estimate of burden for the forms

are as follows:

Collection activity Number of respondents

Responses

per respondent

Total responses

Average time

per response

(in minutes)

Total burden

hours

HRSA Form 504 ................................................................... 22 1 22 8 3

HRSA Form 508:

Borrowers ............................................................................. 12,430 1 12,430 10 2,071

Employers ............................................................................. 7,550 1.646 12,430 5 1,035

Borrower Loan Status Update Electronic Submission ......... 22 8,498 186,970 3 9,348

Loan Purchase/consolidation Electronic Submission ........... 22 850 18,700 4 1,246

Total ............................................................................... 20,046 ........................ 227,552 ........................ 13,703

Written comments and

recommendations concerning the

proposed information collection should

be sent within 30 days of this notice to:

John Morrall, Human Resources and

Housing Branch, Office of Management

and Budget, New Executive Office

Building, Room 10235, Washington, DC

20503.

Dated: June 1, 2000.

Jane Harrison,

Director, Division of Policy Review and

Coordination.

[FR Doc. 00–14273 Filed 6–6–00; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Proposed Collection; Comment

Request; The Family Health Survey

(Validation of a Family History of

Cancer Questionnaire for Risk Factor

Surveillance)

SUMMARY: In compliance with the

requirement of Section 3506(c)(2)(A) of

the Paperwork Reduction Act of 1995,

for opportunity for public comment on

proposed data collection projects, the

National Cancer Institute (NCI), the

National Institutes of Health (NIH) will

publish periodic summaries of proposed

projects to be submitted to the Office of

Management and Budget (OMB) for

review and approval.

Proposed Collection

Title The Family Health Survey

(Validation of a Family History of

Cancer Questionnaire for Risk Factor

Surveillance). Type of Information

Collection Request: New. Need and Use

of Information Collection: In this

methologic pilot study, the NCI will

develop a family history of cancer

questionnaire for use in cancer risk

factor surveillance, and will evaluate

how accurately individuals in the

general population can report major

cancers occurring in their immediate

and extended family. This study is

needed because there are currently no

validated questionnaires with which to

collect comprehensive data for assessing

the burden of family history of cancer in

the U.S. population, and no general

population estimates of reporting error

for the major cancers that affect families.

The results on reporting accuracy will

be used to determine whether the

quality of data is sufficient to justify

conducting a comprehensive national

prevalence study of family history of

cancer. The questionnaire will be

administered in a telephone survey of

adults, age 25 to 64 years who will be

randomly selected from households in

Connecticut. Respondents will be asked

to report about family structure and

cancer diagnoses occurring in their first

and second degree relatives. Positive

and negative reports of five major cancer

sites (i.e. breast, prostate, colorectal,

lung, and ovarian cancers) will be

validated for approximately four

relatives per respondent through data

linkage to state and federal health

registries or by review of death

certificates and medical records. Living

relatives and next-of-kin of deceased

relatives may be interviewed as part of

the validation process. Information

about the accuracy of reports and factors

associated with reporting error will help

to evaluate the feasibility of conducting

surveys on family history of cancer.

Frequency of Response: One-time study.

Affected Public: Individuals or

households. Type of Respondents:

Adults, age 25 to 64, who reside in the

state of Connecticut and their selected

adult relatives over age 25 or the